Literature DB >> 32030222

Increased serum bile acid level is associated with high-risk coronary artery plaques in an asymptomatic population detected by coronary computed tomography angiography.

Bu-Chun Zhang1, Jun-Hong Chen1, Chu-Han Xiang1, Ming-Yu Su1, Xue-Shan Zhang1, Yan-Feng Ma1.   

Abstract

BACKGROUND: There are limited data on the association between serum total bile acid level and coronary plaque characteristics. This study investigated the relationship between serum total bile acid level and the severity of coronary stenosis and coronary plaque features in an asymptomatic population using coronary computed tomography angiography (CTA).
METHODS: A total of 1,137 consecutive participants with no known coronary artery disease (CAD) undergoing CTA as part of a general routine health evaluation were recruited. Serum total bile acid level and clinical parameters were assayed. Coronary stenosis and high-risk plaques features (napkin-ring sign, low-attenuation plaque, spotty calcification, positive remodelling) were evaluated. Associations between serum total bile acid concentration and high-risk coronary plaques was tested through univariate and multivariate analyses.
RESULTS: A total of 101 high-risk coronary plaques subjects and 93 controls were eligible for study inclusion. The severity of coronary artery stenosis and high-risk coronary plaques increased with serum total bile acid level quartiles (all P<0.001). The independent predictor of high-risk coronary plaques in multivariate analysis was serum total bile acid level (P<0.001). Receiver operating characteristic (ROC) confirmed that serum total bile acid concentration significantly differentiated high-risk coronary plaques [the area under the curve (AUC) =0.876; P<0.001, with a sensitivity of 87.13% and a specificity of 86.02%].
CONCLUSIONS: Higher serum total bile acid level was associated with the severity of coronary artery stenosis and high-risk coronary artery plaques detected by CTA in asymptomatic populations. 2019 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Circulating bile acid; atherosclerosis; coronary computed tomography angiography (CTA); plaque

Year:  2019        PMID: 32030222      PMCID: PMC6988058          DOI: 10.21037/jtd.2019.12.16

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  27 in total

1.  Endothelial injury. Association with elevations of serum bile acid and cholesterol concentration in biliary-obstructed rats.

Authors:  F Parl; W H Gutstein; A F D'Aguillo; A Baez
Journal:  Atherosclerosis       Date:  1975 Mar-Apr       Impact factor: 5.162

2.  Coronary plaque characteristics in computed tomography and 2-year outcomes: The PREDICT study.

Authors:  Hideya Yamamoto; Yasuki Kihara; Toshiro Kitagawa; Norihiko Ohashi; Eiji Kunita; Yoshitaka Iwanaga; Kazuhiro Kobuke; Shunichi Miyazaki; Tomohiro Kawasaki; Shinichiro Fujimoto; Hiroyuki Daida; Takashi Fujii; Aki Sato; Tomokazu Okimoto; Sachio Kuribayashi
Journal:  J Cardiovasc Comput Tomogr       Date:  2018-07-07

3.  Long-term prognostic value of morphological plaque features on coronary computed tomography angiography.

Authors:  Tom Finck; Antonija Stojanovic; Albrecht Will; Eva Hendrich; Stefan Martinoff; Jörg Hausleiter; Martin Hadamitzky
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-03-01       Impact factor: 6.875

4.  The association of bile acid excretion and atherosclerotic coronary artery disease.

Authors:  Gideon Charach; Itamar Grosskopf; Alexander Rabinovich; Michael Shochat; Moshe Weintraub; Pavel Rabinovich
Journal:  Therap Adv Gastroenterol       Date:  2011-03       Impact factor: 4.409

5.  Reversing the Cytotoxicity of Bile Acids by Supramolecular Encapsulation.

Authors:  Ying-Ming Zhang; Xun Xu; Qilin Yu; Yao-Hua Liu; Yu-Hui Zhang; Li-Xia Chen; Yu Liu
Journal:  J Med Chem       Date:  2017-04-18       Impact factor: 7.446

Review 6.  A role of the bile salt receptor FXR in atherosclerosis.

Authors:  Jurre Hageman; Hilde Herrema; Albert K Groen; Folkert Kuipers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08       Impact factor: 8.311

7.  Quantification of coronary low-attenuation plaque volume for long-term prediction of cardiac events and reclassification of patients.

Authors:  S Deseive; R Straub; M Kupke; A Broersen; P H Kitslaar; S Massberg; M Hadamitzky; J Hausleiter
Journal:  J Cardiovasc Comput Tomogr       Date:  2018-01-06

8.  Prognosis of patients with mild-moderate coronary artery stenosis detected by coronary computed tomography angiography.

Authors:  Hikmet Yorgun; Uğur Canpolat; Kudret Aytemir; Tuncay Hazırolan; Hamza Sunman; Ahmet Hakan Ateş; Levent Sahiner; Sevilay Karahan; Ergün Barış Kaya; Lale Tokgözoğlu; Giray Kabakçı; Ali Oto
Journal:  Int J Cardiol       Date:  2012-11-30       Impact factor: 4.164

Review 9.  Heart and bile acids - Clinical consequences of altered bile acid metabolism.

Authors:  Tharni Vasavan; Elisa Ferraro; Effendi Ibrahim; Peter Dixon; Julia Gorelik; Catherine Williamson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-01-06       Impact factor: 5.187

10.  The role of bile Acid excretion in atherosclerotic coronary artery disease.

Authors:  Gideon Charach; Alexander Rabinovich; Ori Argov; Moshe Weintraub; Pavel Rabinovich
Journal:  Int J Vasc Med       Date:  2011-09-12
View more
  2 in total

1.  Serum Metabolomics Reveals Distinct Profiles during Ischemia and Reperfusion in a Porcine Model of Myocardial Ischemia-Reperfusion.

Authors:  Eric Goetzman; Zhenwei Gong; Dhivyaa Rajasundaram; Ishan Muzumdar; Traci Goodchild; David Lefer; Radhika Muzumdar
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

2.  Myocardial Infarction and Coronary Artery Disease in Menopausal Women With Type 2 Diabetes Mellitus Negatively Correlate With Total Serum Bile Acids.

Authors:  Xunxun Feng; Guangyao Zhai; Jiaqi Yang; Yang Liu; Yujie Zhou; Qianyun Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-05       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.